Joint (JYNT) Cash & Equivalents (2013 - 2026)

Joint has disclosed Cash & Equivalents across 14 years of filings, most recently posting $742730.0 for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $742730.0, down 96.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $742730.0 (down 96.61% YoY), and the FY2025 annual result was $19.2 million, changed N/A from the prior year.
• Cash & Equivalents came in at $742730.0 for Q1 2026 at Joint, down from $19.2 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $21.9 million in Q1 2025 to a low of $742730.0 in Q1 2026.
• The 5-year median for Cash & Equivalents is $14.8 million (2023), against an average of $12.9 million.
• Across the five-year window, Cash & Equivalents surged 56.25% in 2023 and slumped 96.61% in 2026, its largest moves.
• Joint's Cash & Equivalents stood at $10.6 million in 2022, then sank by 89.95% to $1.1 million in 2023, then soared by 1855.13% to $20.7 million in 2024, then decreased by 7.42% to $19.2 million in 2025, then sank by 96.13% to $742730.0 in 2026.
• The last three Cash & Equivalents figures came in at $742730.0 (Q1 2026), $19.2 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.